Cargando…
Venom-based peptide therapy: insights into anti-cancer mechanism
The 5-year relative survival rate of all types of cancer has increased significantly over the past three decades partly due to the targeted therapy. However, still there are many targeted therapy drugs could play a role only in a portion of cancer patients with specific molecular alternation. It is...
Autores principales: | Ma, Rui, Mahadevappa, Ravikiran, Kwok, Hang Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725072/ https://www.ncbi.nlm.nih.gov/pubmed/29246030 http://dx.doi.org/10.18632/oncotarget.21740 |
Ejemplares similares
-
Triggering of cancer cell cycle arrest by a novel scorpion venom‐derived peptide—Gonearrestide
por: Li, Bin, et al.
Publicado: (2018) -
Venom Toxins as Potential Targeted Therapies
por: Kwok, Hang Fai
Publicado: (2019) -
Over-Activation of Minichromosome Maintenance Protein 10 Promotes Genomic Instability in Early Stages of Breast Cancer
por: Mughal, Muhammad Jameel, et al.
Publicado: (2022) -
Functional and Proteomic Insights into Aculeata Venoms
por: Dashevsky, Daniel, et al.
Publicado: (2023) -
Novel venom-based peptides (P13 and its derivative—M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGFβ signaling pathways
por: Ma, Rui, et al.
Publicado: (2020)